JP2022549351A5 - - Google Patents

Info

Publication number
JP2022549351A5
JP2022549351A5 JP2022519303A JP2022519303A JP2022549351A5 JP 2022549351 A5 JP2022549351 A5 JP 2022549351A5 JP 2022519303 A JP2022519303 A JP 2022519303A JP 2022519303 A JP2022519303 A JP 2022519303A JP 2022549351 A5 JP2022549351 A5 JP 2022549351A5
Authority
JP
Japan
Prior art keywords
polypeptide
heterodimer protein
protein according
polynucleotide encoding
heavy chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022519303A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022549351A (ja
JP7842011B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/053114 external-priority patent/WO2021062382A1/en
Publication of JP2022549351A publication Critical patent/JP2022549351A/ja
Publication of JP2022549351A5 publication Critical patent/JP2022549351A5/ja
Application granted granted Critical
Publication of JP7842011B2 publication Critical patent/JP7842011B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022519303A 2019-09-27 2020-09-28 ヘテロ二量体タンパク質 Active JP7842011B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962906918P 2019-09-27 2019-09-27
US62/906,918 2019-09-27
PCT/US2020/053114 WO2021062382A1 (en) 2019-09-27 2020-09-28 Heterodimeric proteins

Publications (3)

Publication Number Publication Date
JP2022549351A JP2022549351A (ja) 2022-11-24
JP2022549351A5 true JP2022549351A5 (https=) 2023-10-06
JP7842011B2 JP7842011B2 (ja) 2026-04-07

Family

ID=75166489

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022519303A Active JP7842011B2 (ja) 2019-09-27 2020-09-28 ヘテロ二量体タンパク質

Country Status (10)

Country Link
US (2) US20210130495A1 (https=)
EP (1) EP4034570A4 (https=)
JP (1) JP7842011B2 (https=)
KR (1) KR20220069935A (https=)
CN (1) CN114787186B (https=)
AU (1) AU2020355253A1 (https=)
BR (1) BR112022004789A2 (https=)
IL (1) IL291618A (https=)
MX (1) MX2022003149A (https=)
WO (1) WO2021062382A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3428194T (lt) 2017-07-14 2021-12-10 Immatics Biotechnologies Gmbh Pagerinta dvejopo savitumo polipeptido molekulė
WO2022233956A1 (en) 2021-05-05 2022-11-10 Immatics Biotechnologies Gmbh Antigen binding proteins specifically binding prame

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE299938T1 (de) * 1997-05-02 2005-08-15 Genentech Inc Ein verfahren zur herstellung multispezifischer antikörper die heteromultimere und gemeinsame komponenten besitzen
US7662925B2 (en) * 2002-03-01 2010-02-16 Xencor, Inc. Optimized Fc variants and methods for their generation
WO2005047327A2 (en) * 2003-11-12 2005-05-26 Biogen Idec Ma Inc. NEONATAL Fc RECEPTOR (FcRn)-BINDING POLYPEPTIDE VARIANTS, DIMERIC Fc BINDING PROTEINS AND METHODS RELATED THERETO
TW201302793A (zh) * 2010-09-03 2013-01-16 Glaxo Group Ltd 新穎之抗原結合蛋白
US10689447B2 (en) * 2011-02-04 2020-06-23 Genentech, Inc. Fc variants and methods for their production
CA2843158A1 (en) * 2011-08-26 2013-03-07 Merrimack Pharmaceuticals, Inc. Tandem fc bispecific antibodies
BR112014010580B1 (pt) * 2011-11-04 2021-01-12 Zymeworks, Inc. constructo de fc heteromultimérico isolado, composição, uso de um constructo de fc heteromultimérico isolado, composição de ácido nucléico e método para expressar o constructo de fc heteromultimérico isolado
ES2876009T3 (es) * 2012-12-27 2021-11-11 Chugai Pharmaceutical Co Ltd Polipéptido heterodimerizado
MY203000A (en) * 2016-10-14 2024-06-01 Xencor Inc Il15/il15r� heterodimeric fc-fusion proteins
KR20200014379A (ko) * 2017-06-05 2020-02-10 얀센 바이오테크 인코포레이티드 비대칭 ch2-ch3 영역 돌연변이를 갖는 조작된 다중특이성 항체 및 다른 다량체 단백질
CN110028584B (zh) * 2018-01-12 2021-04-06 北京科昕生物科技有限公司 针对egfr蛋白和met蛋白的双特异性抗体
SG11202104136YA (en) * 2018-10-23 2021-05-28 Dragonfly Therapeutics Inc Heterodimeric fc-fused proteins

Similar Documents

Publication Publication Date Title
JP6490038B2 (ja) 交差結合領域の配向性を有する二重可変領域抗体様結合タンパク質
RU2722788C2 (ru) Иммуноактивирующая антигенсвязывающая молекула
CN109963876B (zh) 抗pd-1/抗her2天然抗体结构样异源二聚体形式双特异抗体及其制备
JP2020195399A5 (https=)
RS20140202A1 (sr) Biospecifični imunovezivni proteini usmereni protiv tnf i il-17
JP2023159379A (ja) Ｐｄ－１とｖｅｇｆを標的とした四価二重特異性抗体、その製造方法および用途
JP2022553830A (ja) Ｎ末端ｓｃＦｖ多重特異性結合分子
RS64830B1 (sr) Anti-tnf-alfa antitela i njihovi funkcionalni fragmenti
JP2019505565A5 (https=)
JP2024539630A5 (https=)
JP2022549351A5 (https=)
JP2024542235A5 (https=)
JP2024502095A (ja) 二重または多重特異性抗体｛Ｂｉ ｏｒ Ｍｕｌｔｉ－Ｓｐｅｃｉｆｉｃ Ａｎｔｉｂｏｄｙ｝
CN121002062A (zh) Fgfr3结合分子及其使用方法
CN115551892A (zh) 用于耗竭调节性t细胞的双特异性融合蛋白
US20250282874A1 (en) Bifunctional protein, and preparation thereof and use thereof
WO2025092987A1 (zh) 基于Fc区的异二聚体分子及其用途
HK40050601A (en) Dual variable region antibody-like binding proteins having cross-over binding region orientation
RU2021137311A (ru) ИММУНОЛОГИЧЕСКАЯ ТОЛЕРАНТНОСТЬ К MAdCAM
HK1247929A1 (en) Dual variable region antibody-like binding proteins having cross-over binding region orientation
HK1247929B (en) Dual variable region antibody-like binding proteins having cross-over binding region orientation
BR112019010051B1 (pt) Anticorpo biespecífico heterodimérico, polinucleotídeo isolado, vetor de expressão recombinante, composição, método de produzir o anticorpo biespecífico heterodimérico e uso do anticorpo biespecífico heterodimérico
HK1194744B (en) Dual variable region antibody-like binding proteins having cross-over binding region orientation